Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Recombinant Human Growth Hormone Injection in Patients With Prader-Willi Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the efficacy and safety of recombinant human growth hormone injections in patients with Prader-Willi syndrome; the study …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prader-willi Syndrome

Drugs mentioned

• Recombinant human growth hormone (somatropin)

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Prader-Willi Syndrome | Phase 3 | Status: UNKNOWN